Evidence map›Paper›PMID 35329765›Full record

ArticleMaterials (Basel, Switzerland)2022

Hydrophobic Recovery of PDMS Surfaces in Contact with Hydrophilic Entities: Relevance to Biomedical Devices.

Tomoo Tsuzuki, Karine Baassiri, Zahra Mahmoudi, Ayyappasamy Sudalaiyadum Perumal, Kavya Rajendran, Gala Montiel Rubies, Dan V Nicolau

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. PDMS as a Substrate for Lipid Bilayers.Langmuir : the ACS journal of surfaces and colloids · 2023
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomoo TsuzukiFaculty of Engineering and Industrial Science, Industrial Research Institute Swinburne, Swinburne University of Technology, Melbourne, VIC 3122, Australia.
Karine BaassiriDepartment of Bioengineering, Faculty of Engineering, McGill University, Montreal, QC H3A 0E9, Canada.
Zahra MahmoudiDepartment of Bioengineering, Faculty of Engineering, McGill University, Montreal, QC H3A 0E9, Canada.
Ayyappasamy Sudalaiyadum PerumalDepartment of Bioengineering, Faculty of Engineering, McGill University, Montreal, QC H3A 0E9, Canada.ORCID 0000-0002-1360-9152
Kavya RajendranDepartment of Bioengineering, Faculty of Engineering, McGill University, Montreal, QC H3A 0E9, Canada.
Gala Montiel RubiesDepartment of Bioengineering, Faculty of Engineering, McGill University, Montreal, QC H3A 0E9, Canada.ORCID 0000-0002-2194-8445
Dan V NicolauFaculty of Engineering and Industrial Science, Industrial Research Institute Swinburne, Swinburne University of Technology, Melbourne, VIC 3122, Australia.

Funding

European Commission FP6-NMP IP 515803Natural Sciences and Engineering Research Council RGPIN-2016-05019
6 · The paper itself

Abstract

Polydimethylsiloxane (PDMS), a silicone elastomer, is increasingly being used in health and biomedical fields due to its excellent optical and mechanical properties. Its biocompatibility and resistance to biodegradation led to various applications (e.g., lung on a chip replicating blood flow, medical interventions, and diagnostics). The many advantages of PDMS are, however, partially offset by its inherent hydrophobicity, which makes it unsuitable for applications needing wetting, thus requiring the hydrophilization of its surface by exposure to UV or O

Indexed as

Atomic Force Microscopybiomedical devicescathetersdimethylpolysiloxanegas embolismhydrophobic recovery

Identifiers

PMID35329765
PMCPMC8950181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.